Press Resease

Respiratory Disease Testing Market - Global Industry Analysis

Respiratory Disease Testing Market by Product (Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, and Other Tests), By End-user (Hospitals, Physician Offices, and Clinical Laboratories): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 19-Aug-2021 Category: Medical Device Report Format : PDF Pages: 140 Report Code: ZMR-114 Status : Published

The global Respiratory Disease Testing market accounted for USD 3.0 Billion in 2020 and is expected to reach USD 4.2 Billion by 2028, growing at a CAGR of around 3.8% between 2021 and 2028.

Description

Market Overview     

The global Respiratory Disease Testing market accounted for USD 3.0 Billion in 2020 and is expected to reach USD 4.2 Billion by 2028, growing at a CAGR of around 3.8% between 2021 and 2028.      

The respiratory system is one of the vital systems of human body. Respiratory system plays an important role in breathing. Breathing is usually habitual, controlled automatically by the respiratory center at the base of the brain. In addition, the respiratory system also helps to stabilize blood-alkaline balance (pH), remove toxic waste and regulates temperature. Respiratory diseases inhibit this usual operation of the respiratory system and are usually caused as a result of the inhalation of dangerous agents, smoking, and unhealthy lifestyles.

COVID-19 Impact Analysis  

The global Respiratory Disease Testing market has witnessed a growth during the pandemic. This is mainly attributed to the fact that the COVID-19 pandemic situation has led to the rise in demand for public health surveillance and clinical care. However, the rising difficulty in health care delivery has slightly challenged the market in 2020.

However, the market would remain bullish in upcoming year.  The growth of the global Respiratory Disease Testing market size is estimated on the basis of the COVID-19 outbreak. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.

Global Respiratory Disease Testing Market Size

Growth Factors

Respiratory tests such as spirometry, lung volume, peak flow test, imaging, blood gas test, and few other tests are used to diagnose the respiratory disease. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases Moreover, technological advancements and growing aged population would drive the global respiratory disease testing market. However, portable spirometers and low adoption rate of digital radiography may curb the growth of respiratory disease testing market during the forecast period. However, the budding market in Asia-Pacific can act as a potential opportunity for respiratory disease testing market during the forecast period.

Report Scope:  

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview  

Based on the type of the test, the global respiratory disease testing market has been segmented into imaging test, peak flow test, blood gas test, spirometry, lung volume test, and other tests. The imaging test segment holds the largest share of the global respiratory disease testing market. The global respiratory disease testing market is segmented into three major end-user segments i.e. physician offices, hospitals, and clinical laboratories. Hospitals hold the largest market share of respiratory disease testing market in 2020.

Global Respiratory Disease Testing Market Share

Regional Analysis Preview  

North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global respiratory disease testing market. North America holds the largest market share for respiratory disease testing in 2020. The dominance of the region was primarily due to rising popularity of portable devices, increasing the prevalence of respiratory diseases and growing demand for home health care devices and services. The respiratory disease testing market in Asia-Pacific is expected to grow at the fastest growth rate during the forecast period. Latin America is projected to expand at a noticeable growth rate during the forecast period.

Global Respiratory Disease Testing Market Regional Analysis

Key Market Players & Competitive Landscape

Some of the major players of the global Respiratory Disease Testing market include Medical Technologies, Inc., Carestream Health, Inc., SDI Diagnostics, Nihon Kohden Corporation, CareFusion Corporation, Smiths Medical, COSMED, Perkin Elmer, Inc., Philips Healthcare, MGC Diagnostic Corporation, Futuremed America, Inc. and GE Healthcare among others.

The global Respiratory Disease Testing Market is segmented as follows:

By Products

  • Lung Volume
  • Imaging
  • Spirometry
  • Peak Flow
  • Blood Gas
  • Other Tests

By End-user

  • Hospitals
  • Physician Offices
  • Clinical Laboratories

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, By End-user
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Respiratory Disease Testing Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Respiratory Disease Testing Market – Product Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. Lung Vulume
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Imaging
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Spirometry
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Peak Flow
      • 4.5.1. Market Size and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Blood Gas
      • 4.6.1. Market Size and Forecast, By Region (USD Billion)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Other Tests
      • 4.7.1. Market Size and Forecast, By Region (USD Billion)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Respiratory Disease Testing Market – End-user Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By End-user, 2020 & 2028
    • 5.2. Hospitals
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Physician Offices
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Clinical Laboratories
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Respiratory Disease Testing Market – Regional Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 6.2.3. North America Market Revenue, By End-user, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By End-user, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Product, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By End-user, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By End-user, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By End-user, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Product, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By End-user, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Product, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By End-user, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By End-user, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Product, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By End-user, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Product, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By End-user, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By End-user, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By End-user, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Product, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By End-user, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By End-user, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Product, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By End-user, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By End-user, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By End-user, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By End-user, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By End-user, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By End-user, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By End-user, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By End-user, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By End-user, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By End-user, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By End-user, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By End-user, 2016 – 2028
  • Chapter No. 7: Respiratory Disease Testing Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Respiratory Disease Testing Market: Company Market Share, 2019
      • 8.1.2. Global Respiratory Disease Testing Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Respiratory Disease Testing Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Respiratory Disease Testing Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Medical Technulogies, Inc.
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Carestream Health, Inc.
    • 9.3. SDI Diagnostics
    • 9.4. Nihon Kohden Corporation
    • 9.5. CareFusion Corporation
    • 9.6. Smiths Medical
    • 9.7. COSMED
    • 9.8. Perkin Elmer, Inc.
    • 9.9. Philips Healthcare
    • 9.10. MGC Diagnostic Corporation
    • 9.11 Futuremed America, Inc.
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By End-user
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Respiratory Disease Testing Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Product, 2020 & 2028 
FIG NO. 7. Global Respiratory Disease Testing Market for Lung Volume, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Respiratory Disease Testing Market for Lung Volume, By Country, 2020 & 2028
FIG NO. 9. Global Respiratory Disease Testing Market for Imaging, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Respiratory Disease Testing Market for Imaging, By Country, 2020 & 2028
FIG NO. 11. Global Respiratory Disease Testing Market for Spirometry, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Respiratory Disease Testing Market for Spirometry, By Country, 2020 & 2028
FIG NO. 13. Global Respiratory Disease Testing Market for Peak Flow, Revenue (USD Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Respiratory Disease Testing Market for Peak Flow, By Country, 2020 & 2028
FIG NO. 15. Global Respiratory Disease Testing Market for Blood Gas, Revenue (USD Billion) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Respiratory Disease Testing Market for Blood Gas, By Country, 2020 & 2028
FIG NO. 17. Global Respiratory Disease Testing Market for Other Tests, Revenue (USD Billion) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Respiratory Disease Testing Market for Other Tests, By Country, 2020 & 2028
FIG NO. 19. Market Revenue Share, By End-user, 2020 & 2028
FIG NO. 20. Global Respiratory Disease Testing Market for Hospitals, Revenue (USD Billion) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Respiratory Disease Testing Market for Hospitals, By Country, 2020 & 2028 
FIG NO. 22. Global Respiratory Disease Testing Market for Physician Offices, Revenue (USD Billion) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Respiratory Disease Testing Market for Physician Offices, By Country, 2020 & 2028
FIG NO. 24. Global Respiratory Disease Testing Market for Clinical Laboratories, Revenue (USD Billion) 2016 – 2028 
FIG NO. 25. Comparative Revenue Analysis of Respiratory Disease Testing Market for Clinical Laboratories, By Country, 2020 & 2028
FIG NO. 26. Global Respiratory Disease Testing Market Revenue Share, By Region, 2020 & 2028
FIG NO. 27. North America Respiratory Disease Testing Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 28. Porter’s Five Forces Analysis for Global Respiratory Disease Testing Market
FIG NO. 29. PEST Analysis for Global Respiratory Disease Testing Market
FIG NO. 30. Pricing Analysis for Global Respiratory Disease Testing Market
FIG NO. 31. Value Chain Analysis for Global Respiratory Disease Testing Market
FIG NO. 32. Company Share Analysis, 2019
FIG NO. 33. Radar Determinant Chart, 2019
FIG NO. 34. Company Strategic Developments – Heat Map Analysis
FIG NO. 35. Medical Technologies, Inc. Business Segment Revenue Share, 2020 (%)
FIG NO. 36. Medical Technologies, Inc. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 37. Market Channels
FIG NO. 38. Marketing Channel Development Trend
FIG NO. 39. Growth in World Gross Product, 2008-2018
FIG NO. 40. Research Methodology – Detailed View
FIG NO. 41. Research Methodology
 


List of Tables 

TABLE NO. 1. Global Respiratory Disease Testing Market: Snapshot
TABLE NO. 2. Quarterly Respiratory Disease Testing Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Respiratory Disease Testing Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Respiratory Disease Testing Market for Lung Volume, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Respiratory Disease Testing Market for Imaging, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Respiratory Disease Testing Market for Spirometry, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Respiratory Disease Testing Market for Peak Flow, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Respiratory Disease Testing Market for Blood Gas, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. Global Respiratory Disease Testing Market for Other Tests, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Respiratory Disease Testing Market for Hospitals, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13 Global Respiratory Disease Testing Market for Physician Offices, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14. Global Respiratory Disease Testing Market for Clinical Laboratories, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Respiratory Disease Testing Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 16. North America Respiratory Disease Testing Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 17. North America Respiratory Disease Testing Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 18. North America Respiratory Disease Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 19. U.S. Respiratory Disease Testing Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 20. U.S. Respiratory Disease Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 21. Canada Respiratory Disease Testing Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 22. Canada Respiratory Disease Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 23. Mexico Respiratory Disease Testing Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 24. Mexico Respiratory Disease Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 25. Drivers for the Respiratory Disease Testing Market: Impact Analysis
TABLE NO. 26. Restraints for the Respiratory Disease Testing Market: Impact Analysis
TABLE NO. 27. Major Buyers of Respiratory Disease Testing  
TABLE NO. 28. Distributors/Traders List of Respiratory Disease Testing
TABLE NO. 29. Global Respiratory Disease Testing Market, Company Market Revenue, 2016 – 2019 (USD Billion) 
TABLE NO. 30: Global Respiratory Disease Testing Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   


 

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Respiratory Disease Testing market. Zion Research has collected and analyzed key data belong to the global Respiratory Disease Testing market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined afterconducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Respiratory Disease Testing across the world has been calculated through primary and secondary research.

Zion Research employs combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include, STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assistedin validation of findings from secondary research and to understand key trends in the Respiratory Disease Testing industry. Primary research makes up major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Respiratory Disease Testing market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

The respiratory tract performs the function of inhaling oxygen from the atmosphere into the lungs, transferring of the oxygen to the blood, and exhaling carbon dioxide outside of the body. Breathing is usually habitual, controlled automatically by the respiratory center at the base of the brain. In addition, the respiratory system also helps to stabilize blood-alkaline balance (pH), remove toxic waste and regulates temperature. Respiratory diseases inhibit this usual operation of the respiratory system and are usually caused as a result of the inhalation of dangerous agents, smoking, and unhealthy lifestyles. Besides this other factors such as genetic factors, infections either indirectly or directly may also cause respiratory ailments. There are many disorders and infections of the respiratory system. Infections occur more commonly in the respiratory tract as compared to other organs in the body. The respiratory testing devices aid in detecting chronic or acute respiratory diseases; which is very necessary for the treatment to people with respiratory damages.

Respiratory tests such as spirometry, lung volume, peak flow test, imaging, blood gas test, and few other tests are used to diagnose the respiratory disease. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. More than 200 million people globally are suffering from asthma, and there have more than 3 million deaths worldwide due to COPD. Moreover, technological advancements and growing aged population would drive the global respiratory disease testing market. However, portable spirometers and low adoption rate of digital radiography may curb the growth of respiratory disease testing market during the forecast period. However, the budding market in Asia-Pacific can act as a potential opportunity for respiratory disease testing market during the forecast period.

Global Respiratory Disease Testing Market

Based on the type of the test, the global respiratory disease testing market has been segmented into imaging test, peak flow test, blood gas test, spirometry, lung volume test, and other tests. The imaging test segment holds the largest share of the global respiratory disease testing market. The dominance of the segment was mainly due to high demand for imaging tests, especially X-ray. In addition, doctors insist for these tests as they are considered the primary tests for diagnosis of respiratory diseases. While the spirometry test segment is projected to be the fastest growing segment during the forecast period due to its effectiveness and accurate diagnostic results in a short period of time. 

The global respiratory disease testing market is segmented into three major end-user segments i.e. physician offices, hospitals, and clinical laboratories. Hospitals hold the largest market share of respiratory disease testing market in 2015. Hospitals hold more than 50% share of global respiratory disease testing market. The segment dominated the market as most of the respiratory diagnostic instruments, particularly X-ray machines are mostly available in hospitals. Moreover, doctors favor in-house diagnostic tests for their patients in comparison to outside patients.

North America holds the largest market share for respiratory disease testing in 2015. The dominance of the region was primarily due to rise popularity of portable devices, increasing the prevalence of respiratory diseases and growing demand for home health care devices and services. The respiratory disease testing market in Asia-Pacific is expected to grow at the fastest growth rate during the forecast period. Latin America is projected to expand at a noticeable growth rate during the forecast period.

Major market players in this industry are ndd Medical Technologies, Inc., Carestream Health, Inc., SDI Diagnostics, Nihon Kohden Corporation, CareFusion Corporation, Smiths Medical, COSMED, Perkin Elmer, Inc., Philips Healthcare, MGC Diagnostic Corporation, Futuremed America, Inc. and GE Healthcare among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Respiratory Disease Testing Market was valued at USD 3.0 Billion in 2020.

The global Respiratory Disease Testing Market is expected to reach USD 4.2 Billion by 2028, growing at a CAGR of 3.8% between 2021 to 2028.

Some of the key factors driving the global Respiratory Disease Testing Market growth are increasing prevalence of various respiratory diseases and growing aged population.

North America is expected to remain the dominant region over the forecast period. North America followed by Asia-Pacific and Europe in terms of demand for Respiratory Disease Testing.

Some of the major players of global Respiratory Disease Testing market Medical Technologies, Inc., Carestream Health, Inc., SDI Diagnostics, Nihon Kohden Corporation, CareFusion Corporation, Smiths Medical, COSMED, Perkin Elmer, Inc., Philips Healthcare, MGC Diagnostic Corporation, Futuremed America, Inc. and GE Healthcare among others.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed